Lithotripsy Devices Market Size & Growth Forecast 2026–2035, By Segments (Type, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Lithotripsy Devices Market size was over USD 1.41 Billion in 2025 and is likely to grow at a 6.5% CAGR between 2026 and 2035, attaining USD 2.65 Billion by 2035. The industry revenue for 2026 is assessed at USD 1.49 billion.
Get more details on this report
Request Free Sample ReportLithotripsy Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America leads the market through established hospital networks, high urology procedure volumes, advanced technology adoption, and steady demand for equipment upgrades across care settings.
- Asia Pacific is projected to grow at a 7.35% CAGR, supported by expanding hospital infrastructure, broader access to urology care, and increasing adoption of modern minimally invasive stone treatment procedures.
Segment Momentum
- Extracorporeal Shock Wave Lithotripsy Devices captured a 53.55% share in 2025 because their non-invasive approach supports efficient treatment, broad clinical adoption, and high patient throughput across healthcare settings.
- Ambulatory Surgical Centers are the fastest-growing end-use segment as more lithotripsy procedures shift toward efficient outpatient care with streamlined scheduling, shorter stays, and focused procedural delivery.
Market Expansion Drivers
- Rising kidney stone prevalence increasing demand for minimally invasive lithotripsy procedures.
- Technological advancements improving precision and safety of next-generation lithotripsy devices.
- Expansion of ambulatory surgical centers supporting outpatient lithotripsy treatment adoption.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Prominent companies in the lithotripsy devices market include Boston Scientific Corporation (United States), Olympus Corporation (Japan), Dornier MedTech GmbH (Germany), Richard Wolf GmbH (Germany), STORZ MEDICAL AG (Switzerland), Medispec Ltd. (Israel), BTL Industries Inc. (United States), Zimmer MedizinSysteme GmbH (Germany), Shenzhen Huikang Medical Apparatus Co., Ltd. (China), MTS Medical UG (Germany).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As kidney stone incidence rises across broader patient groups, providers are seeing a larger procedural pool that increasingly favors non-invasive or minimally invasive treatment pathways over open surgery. This is driving demand for the lithotripsy devices market because urologists and hospitals need equipment that can fragment stones effectively while reducing hospital stays, post-procedure pain, and recovery time. In practice, higher case volumes push treatment centers to expand access to extracorporeal shock wave lithotripsy and advanced intracorporeal systems, reinforcing purchasing decisions around versatile devices that can manage different stone sizes and locations without adding significant surgical burden.
Technological advancements improving precision and safety of next-generation lithotripsy devices
Innovation in imaging guidance, energy delivery, stone targeting, and fragmentation control is reshaping clinician preferences in the lithotripsy devices market by improving procedural accuracy and reducing collateral tissue injury. Hospitals and specialists are more willing to upgrade installed systems when newer platforms support better visualization, more consistent stone clearance, and fewer repeat interventions, since these factors directly affect workflow efficiency and clinical confidence. This is influencing market adoption most strongly in settings where device performance, patient safety, and treatment predictability determine capital allocation and physician choice.
Expansion of ambulatory surgical centers supporting outpatient lithotripsy treatment adoption
The growth of ambulatory surgical centers is changing where stone management is delivered, creating a strong commercial channel for compact, efficient, and procedure-friendly systems in the lithotripsy devices market. As more lithotripsy cases shift to outpatient settings, providers prioritize devices that fit shorter treatment cycles, streamlined staffing models, and faster patient turnover without compromising treatment effectiveness. That shift is aiding market expansion by broadening the base of purchasing facilities beyond large hospitals and encouraging manufacturers to align product design, service models, and training support with the operational needs of ambulatory care.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing prevalence of kidney stones and urological conditions | 2.10% | Short term (≤ 2 yrs) | North America, Europe | Medium | Fast |
| Expansion of minimally invasive lithotripsy procedures | 2.20% | Medium term (2–5 yrs) | Europe, Asia Pacific | Medium | Moderate |
| Innovation in lithotripsy device design and efficiency | 2.20% | Long term (5+ yrs) | North America, Asia Pacific | Medium | Moderate |
| Rising kidney stone prevalence increasing demand for minimally invasive lithotripsy procedures | 2.00% | Moderate | North America, Asia Pacific | High | Near Term |
| Technological advancements improving precision and safety of next-generation lithotripsy devices | 1.80% | Moderate | Europe, North America | High | Mid Term |
| Expansion of ambulatory surgical centers supporting outpatient lithotripsy treatment adoption | 1.50% | Moderate | North America, Europe | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the largest regional market share in 2025 for the lithotripsy devices market, bolstered by broad access to established hospital networks, higher procedural volumes for urology care, and faster integration of advanced stone management technologies into routine clinical practice. The region’s leadership is strengthened by the presence of well-equipped treatment centers that can adopt extracorporeal and minimally invasive lithotripsy systems efficiently, alongside physician familiarity with device-based stone fragmentation procedures. This operating environment keeps utilization steady across inpatient and outpatient settings, helping sustain demand for replacement systems, technology upgrades, and procedure-support equipment.
Asia Pacific is projected to expand at a 7.35% CAGR over the forecast period, with growth in the lithotripsy devices market being propelled by rising access to urological treatment, expanding hospital infrastructure, and wider adoption of modern stone treatment procedures across developing healthcare systems. As more facilities invest in specialized equipment and patients gain greater access to diagnosis and intervention, demand is accelerating for lithotripsy platforms that can support less invasive treatment pathways. The region’s momentum is also shaped by the practical shift from limited conventional management toward device-enabled procedures in urban and emerging care centers.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Urology SystemsGermany emphasizes lithotripsy devices offering reliable performance and integration with advanced urology practices. Medical equipment manufacturers continue refining imaging capabilities and treatment accuracy to support specialized clinical procedures.
France 🇫🇷
Clinical Workflow OptimizationFrance is strengthening lithotripsy device utilization by improving access to minimally invasive stone management in hospitals. Procurement decisions increasingly favor systems offering dependable imaging integration and efficient clinical workflows.
Italy 🇮🇹
Specialized Urology ExpansionItaly is expanding lithotripsy device deployment across specialized urology centers seeking effective non-invasive treatment options. Equipment suppliers are focusing on user-friendly systems that support consistent procedural performance and patient care quality.
Japan 🇯🇵
Compact Treatment TechnologiesJapan is advancing lithotripsy device adoption through compact, high-performance systems suited to technologically advanced healthcare facilities. Clinical priorities include patient comfort, procedural efficiency, and consistent treatment outcomes.
South Korea 🇰🇷
Hospital Technology UpgradesSouth Korea continues modernizing urology departments with lithotripsy devices that enhance precision and operational efficiency. Healthcare providers are investing in integrated treatment platforms supporting streamlined diagnosis and intervention.
United States 🇺🇸
Minimally Invasive CareThe U.S. lithotripsy devices market is driven by growing preference for minimally invasive kidney stone treatment and continual hospital technology upgrades. Healthcare providers are adopting advanced systems that improve treatment precision, workflow efficiency, and patient recovery.
Segment Leadership and Growth Trends
Lithotripsy Devices Market Share (%), Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportExtracorporeal Shock Wave Lithotripsy Devices held the leading position in the lithotripsy devices market in 2025, accounting for a 53.55% share. This leadership is underpinned by their established role in non-invasive stone treatment, which supports broad adoption across care settings that prioritize procedural efficiency and patient throughput. Their continued use reflects routine clinical familiarity and the practical advantage of treating appropriate cases without the need for more invasive access, helping this segment preserve its dominant share in the lithotripsy devices market.
Intracorporeal Lithotripsy Devices are emerging as the fastest-growing segment in the lithotripsy devices market as treatment approaches increasingly align with procedures that require direct stone access and targeted fragmentation. Growth is being aided by the practical need for greater procedural precision in cases where non-invasive methods may be less suitable, giving intracorporeal systems stronger momentum relative to alternatives. As clinical settings continue to adopt intervention pathways designed around more controlled stone management, this segment is experiencing stronger uptake at a faster pace.
End-use Segment Analysis: Hospitals (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals represented the largest end-use segment of the lithotripsy devices market in 2025, with a 48.44% share. Their leadership is anchored in the ability to manage a broad range of stone cases, including patients requiring integrated diagnostics, specialist support, and access to more comprehensive procedural infrastructure. This concentration of treatment capabilities allows hospitals to retain the largest share in the lithotripsy devices market, especially where case complexity and peri-procedural management remain important considerations.
Ambulatory Surgical Centers are the fastest-growing end-use segment in the lithotripsy devices market, driven by the rising suitability of selected lithotripsy procedures for efficient outpatient care. Their momentum comes from operating models built around shorter stays, streamlined scheduling, and focused procedural delivery, which make them increasingly attractive for cases that do not require full hospital resources. Compared with traditional inpatient-oriented settings, ambulatory surgical centers are gaining faster adoption as providers respond to demand for more efficient treatment pathways.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Extracorporeal Shock Wave Lithotripsy Devices, Intracorporeal Lithotripsy Devices | Extracorporeal Shock Wave Lithotripsy Devices | Intracorporeal Lithotripsy Devices |
| End-use | Hospitals, Ambulatory Surgical Centers, Others | Hospitals | Ambulatory Surgical Centers |
| Application | Kidney Stones, Ureteral Stones, Pancreatic Stones, Bile Duct Stones | Kidney Stones | Pancreatic Stones |
Competitive Landscape and Market Positioning
1. Boston Scientific Corporation (United States)
2. Olympus Corporation (Japan)
3. Dornier MedTech GmbH (Germany)
4. Richard Wolf GmbH (Germany)
5. STORZ MEDICAL AG (Switzerland)
6. Medispec Ltd. (Israel)
7. BTL Industries Inc. (United States)
8. Zimmer MedizinSysteme GmbH (Germany)
9. Shenzhen Huikang Medical Apparatus Co. Ltd. (China)
10. MTS Medical UG (Germany)
Minimally invasive treatment demand is driving innovation in the lithotripsy devices market. In the lithotripsy devices market, precision energy delivery systems and improved procedural control are enhancing treatment efficiency and patient recovery.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Boston Scientific Corporation | Mar-21 | Boston Scientific acquired Lumenis, expanding its presence in lithotripsy and minimally invasive urology treatment solutions. The acquisition strengthens its portfolio in energy-based medical devices and supports broader adoption of advanced stone treatment technologies across global healthcare markets. |
| Dornier MedTech | Mar-21 | Dornier MedTech achieved EU MDR certification for its Class IIb lithotripsy systems, including the Delta III lithotripter and UIMS platform. The certification enhances regulatory compliance and strengthens its competitive positioning in the European medical device market for extracorporeal shock wave lithotripsy systems. |
| Avvio Medical | May-25 | Avvio Medical reported first patient treatments using its investigational Enhanced Lithotripsy System following FDA IDE approval. The milestone advances clinical validation of next-generation lithotripsy technology designed to improve kidney stone fragmentation and minimally invasive treatment outcomes. |
| SonoMotion | Nov-24 | SonoMotion received FDA de-novo clearance for its Stone Clear device, an ultrasound-based platform designed to mobilize residual stone fragments post-lithotripsy. The approval expands post-procedure treatment capabilities and enhances non-invasive stone management workflows. |
| Shvabe Holding | Dec-24 | Shvabe Holding unveiled a certified extracorporeal shock-wave lithotripter aimed at replacing imported systems in Russian clinical settings. The development supports domestic medical device production and expands access to lithotripsy technologies in local healthcare infrastructure. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Lithotripsy Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Lithotripsy Devices Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of lithotripsy devices?
What is the projected value of the lithotripsy devices industry by 2035?
How is the shift toward minimally invasive treatment pathways influencing adoption of lithotripsy devices?
How are technological advancements and the expansion of ambulatory surgical centers reshaping lithotripsy device purchasing decisions?
Why are Extracorporeal Shock Wave Lithotripsy Devices the leading segment in the lithotripsy devices market?
Which end-use segment is growing fastest in the lithotripsy devices market?
What factors make North America the largest lithotripsy devices market?
Why is Asia Pacific experiencing the fastest growth in the lithotripsy devices market?
Which companies dominate the lithotripsy devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization